Michael ZürcherApr 102 minINSIGHTSSwiss Pharmaceutical Market 2023: Further Growth AchievedIn 2023, the Swiss pharmaceutical market showcased significant resilience and innovation, reflecting its pivotal role in the global...
Michael ZürcherNov 22, 20231 minINSIGHTSNew Opportunity in Swiss Market Access: Accelerated Access to Vital MedicinesA new, early submission procedure is set to enable enhanced and tighter parallel processing of Swissmedic and the Federal Office of...
Bettina SchelbertNov 1, 20231 minINSIGHTSSwizzard Pharma AG expands its service offering!We’re excited to announce that we are expanding our range to include launch readiness and marketing services.
Michael ZürcherSep 4, 20232 minINSIGHTSSwitzerland’s Commitment to Healthcare as a Leader in Health Spending and Patent ApplicationSwitzerland's healthcare system is often regarded as a benchmark for high-quality healthcare, as evidenced by the country's high life...
Michael ZürcherApr 20, 20233 minINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty1. Introduction Before a drug finds its way onto the Swiss market, permission to import must be obtained in accordance with the...
Michael ZürcherFeb 15, 20233 minINSIGHTSMarket Access in Switzerland – or how to include medical breakthroughs on the specialties listIntroduction The Swiss healthcare market is one of the most lucrative in Europe. Thanks to solid financing, a healthy mix of private...